Detalhe da pesquisa
1.
Successful autologous hematopoietic stem cell transplants using Salmonella positive products collected from asymptomatic donors.
Transfusion
; 63(4): 861-866, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36880384
2.
Treatment patterns and clinical outcomes of tyrosine kinase inhibitors in chronic-phase CML in clinical practice: 3-year European SIMPLICITY data.
Eur J Haematol
; 106(1): 82-89, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32989776
3.
Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial.
Blood
; 132(4): 393-404, 2018 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29567798
4.
Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis.
Haematologica
; 102(2): 327-335, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27789678
5.
A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis.
N Engl J Med
; 366(9): 799-807, 2012 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22375971
6.
Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes.
Blood
; 120(25): 4945-51, 2012 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-22915641
7.
A phase II multicenter rabbit anti-thymocyte globulin trial in patients with myelodysplastic syndromes identifying a novel model for response prediction.
Haematologica
; 99(7): 1176-83, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24488560
8.
Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies.
Haematologica
; 99(2): 292-8, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23911705
9.
Expansion of effector memory regulatory T cells represents a novel prognostic factor in lower risk myelodysplastic syndrome.
J Immunol
; 189(6): 3198-208, 2012 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22875800
10.
The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosis.
Br J Haematol
; 161(4): 508-16, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23480528
11.
Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.
Blood
; 117(17): 4552-60, 2011 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-21285439
12.
CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia.
Blood
; 117(21): e198-206, 2011 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-21346257
13.
Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia.
Blood
; 118(16): 4384-93, 2011 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21865345
14.
Efficacy, safety and survival with ruxolitinib in patients with myelofibrosis: results of a median 2-year follow-up of COMFORT-I.
Haematologica
; 98(12): 1865-71, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24038026
15.
Low booster uptake in cancer patients despite health benefits.
medRxiv
; 2023 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37961284
16.
SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations.
Blood
; 115(5): 1049-53, 2010 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-19965645
17.
Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia.
Cancer Cell
; 2(2): 117-25, 2002 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12204532
18.
Longitudinal SARS-CoV-2 mRNA Vaccine-Induced Humoral Immune Responses in Patients with Cancer.
Cancer Res
; 81(24): 6273-6280, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34759001
19.
Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency.
J Clin Invest
; 117(9): 2562-9, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17710227
20.
Safety of bloodless autologous stem cell transplantation in Jehovah's Witness patients.
Bone Marrow Transplant
; 55(6): 1059-1067, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31898692